SAN FRANCISCO, CA — Using a device designed to close the patent foramen ovale (PFO) in patients who have had a cryptogenic ischemic stroke may reduce their risk of having another stroke, suggests ...

A group of physicians assembled Tuesday on behalf of the FDA to rule that St. Jude Medical’s new heart device appears safe and effective in stroke prevention, according to the Minneapolis Star Tribune ...

Abbott Laboratories ABT recently launched its Amplatzer Talisman PFO Occlusion System in Europe. The Talisman device aims to treat patent foramen ovale (PFO) patients who have had a stroke and are at ...

The device, used to lower the risk of stroke, is intended for patients who already had one stroke caused by a blood clot passing through a hole in the heart and into the brain. The device prevents a ...

Abbott has launched its Amplatzer Tailsman PFO Occlosion System in Europe. The device is designed to treat people with a patent foramen ovale (PFO) who have had a stroke and are at risk of having ...

Abbott announced the European launch of its Amplatzer Talisman PFO Occlusion System to treat people with a patent foramen ovale (PFO) – a hole in the heart that doesn't close following birth – who ...

MIAMI, FL – OCTOBER 25, 2012 – A clinical trial that compared catheter-based PFO closure using an investigational device found that there was no significant reduction in ischemic and bleeding events ...